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t e c h n i c a l r e p o r t s A substantial proportion of tumors consist of genotypically distinct subpopulations of cancer cells. This intratumor genetic heterogeneity poses a substantial challenge for the implementation of precision medicine. Single-cell genomics constitutes a powerful approach to resolve complex mixtures of cancer cells by tracing cell lineages and discovering cryptic genetic variations that would otherwise be obscured in tumor bulk analyses. Because of the chemical alterations that result from formalin fixation, single-cell genomic approaches have largely remained limited to fresh or rapidly frozen specimens. Here we describe the development and validation of a robust and accurate methodology to perform whole-genome copy-number profiling of single nuclei obtained from formalin-fixed paraffinembedded clinical tumor samples. We applied the single-cell sequencing approach described here to study the progression from in situ to invasive breast cancer, which revealed that ductal carcinomas in situ show intratumor genetic heterogeneity at diagnosis and that these lesions may progress to invasive breast cancer through a variety of evolutionary processes.
The coexistence of genetically distinct cancer cells within a tumor, referred to as intratumor genetic heterogeneity (ITGH), is well documented in human cancers [1] [2] [3] [4] [5] . Although in some cancers ITGH is a widespread phenomenon 1, 6 , in breast cancer varying degrees of heterogeneity have been documented 7, 8 . Sequencing studies have shed light on ITGH 9,10 ; however, standard sequencing methods provide a compound measure of clonal complexity, with subclonal frequencies of somatic alterations being inferred statistically 11, 12 . Single-cell genomic methods [13] [14] [15] [16] [17] have been developed to provide orthogonal and complementary information to move beyond statistical inference and facilitate in-depth understanding of cancer clonal hierarchy and genetic heterogeneity 8, 18 .
Single-cell genomics have so far been limited to the analysis of fresh or rapidly frozen (hereafter referred to as 'fresh/frozen') tissues 13, 15 . Fresh/frozen tumor specimen procurement is not part of the routine clinical and diagnostic practice in most institutions, and for some tumor types such as small tumors or tumors for which near-complete sampling is required for histopathology, fresh/frozen samples cannot be obtained. Hence, fresh/frozen specimens are only available for a subset of cancers and, owing to the generally limited volume of the tumor that is sampled as fresh/frozen, they may not adequately represent the tumors from which they are derived. The majority of human tumor material is routinely formalin-fixed and paraffin-embedded (FFPE) for diagnostic purposes. Molecular analysis of FFPE specimens, however, is challenging, given that formalin fixation introduces several types of artifacts, which are mainly caused by protein and nucleic acid cross-links 19 . Although whole-exome and targeted sequencing analyses have been successfully performed on DNA extracted from FFPE tumor bulk samples 20, 21 , single-cell methods for genomic investigations of FFPE tissue samples have yet to be reported.
Here we describe and validate a robust approach to perform singlecell whole-genome copy-number (CN) profiling from FFPE tissue samples ( Fig. 1) . We demonstrated that CN profiles of nuclei retrieved from matched FFPE and frozen samples of cancer cell lines and neoplastic lesions are equivalent. We validated the approach in clinical diagnostic specimens and gleaned insights into the progression from ductal carcinoma in situ (DCIS) to invasive breast cancer. This methodology makes it possible to apply single-cell sequencing to address biological and/or clinical questions that require FFPE samples.
RESULTS

FFPE single-cell whole-genome CN analysis methodology
Genome-wide CN profiling of single nuclei derived from fresh/frozen tissue involves the isolation of nuclei, followed by DNA-content-based Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samples sorting using flow cytometry to obtain single nuclei in individual wells of 96-well plates, whole-genome amplification (WGA) and sequencing 2, 15 . To develop a method for whole-genome-sequencing-based CN analysis of single cells derived from FFPE samples, we modified our protocol for frozen nuclei 15 to include steps we deemed pertinent to the success of a method for the analysis of FFPE single cells. These steps are: (i) applying a molecular test to prioritize FFPE specimens that are likely to be amenable to single-cell analysis, (ii) incorporating methods to ensure the retrieval of intact nuclei, and (iii) treating isolated nuclei to repair damaged FFPE single-cell DNA ( Fig. 1 and  Supplementary Figs. 1 and 2) .
First, to select FFPE specimens we used a multiplex-PCR 22, 23 assay to define the quality of the DNA extracted from FFPE samples. This assay uses primer sets that amplify four genomic fragments (100 bp, 200 bp, 300 bp and 400 bp in size). Samples producing 300-bp and 400-bp fragments were deemed to be good in quality 22, 23 and were the focus of this study. Tumor samples from eight individual patients in total were processed; of these, tumor samples from four patients yielded ≥300-bp multiplex-PCR fragments ( Supplementary  Fig. 1a,b) . Single cells from these cases and from one case with 200-bp multiplex-PCR fragments were subjected to sequencing. One of the cases with 300-bp multiplex-PCR fragments displayed a heavy immune infiltrate (i.e., >80% of inflammatory cells within tumor clusters and in the tumor stroma, a phenotype observed in <3% of breast cancers) 24 and was not analyzed further (data not shown). Results from four cases are presented ( Table 1) . Second, to retrieve intact nuclei, FFPE blocks were sectioned into 100-µm-thick sections for microdissection 5 . The microdissected tissue was subjected to distinct treatments, including high temperature (to remove protein and DNA cross-links), enzymatic processing (to digest extracellular material using proteases) and mechanical stress (passage through a fine needle to ensure nuclei release). Third, to mitigate artifacts caused by formalin fixation 22 (for example, the introduction of DNA adducts, gaps and nicks), single nuclei were treated with a cocktail of DNA repair enzymes (Online Methods) 25 , which we posited might enhance the performance of the WGA reaction by increasing the number of amplifiable DNA molecules per nucleus. Finally, for WGA, we used a degenerate-oligonucleotide-priming PCR-based method (DOP-PCR) that was previously shown to be suitable for CN analysis of single-cells 2 and poor-quality fragmented 26 DNA. DOP-PCR was chosen over other WGA methods, such as multiple displacement amplification 27 or multiple annealing and looping-based amplification cycles chemistry 28 , owing to its favorable performance with FFPE samples 29, 30 . Figure 1 Schematic representation of the formalin-fixed paraffin-embedded (FFPE) single-cell sequencing platform. The procedure consists of 11 steps involving tissue microdissection, nuclear preparation, and FACS analysis and sorting based on DAPI staining and DNA content (steps 1-5), single-nucleus DNA repair to correct for FFPE-induced DNA damage, whole-genome amplification (WGA), Illumina library preparation and multiplex sequencing (steps 6-10), and bioinformatics analysis (step 11). The multiplex-PCR analysis is used to determine the quality of the DNA extracted from preparations of FFPE nuclei and is performed between steps 3 and 4. Scale bar, 1 mm. *   8   1  3  5  7  9  11 13 15  21  19  17  X  2  4  6  8  10 12 14  18  22 To test this approach, FFPE and frozen-tissue sections from case 1 ( Fig. 2a) , a triple-negative invasive ductal carcinoma, were reviewed by two pathologists (F.C.G. and J.S.R.-F.), microdissected and processed as described for FFPE samples (Online Methods) and for frozen sections 15 ( Supplementary Table 1 ). Multiplex-PCR analysis of bulk FFPE DNA from case 1 yielded PCR fragments of up to 400 bp ( Supplementary Fig. 1a ). Flow cytometry analysis of FFPE nuclei, based on DAPI staining, yielded a ploidy profile similar to that of frozen nuclei, with both showing two distributions at ~2N (diploid) and ~3N (triploid) DNA content ( Fig. 2b) . Cytometric parameters, such as forward scatter, side scatter and DAPI signal, were concordant between the FFPE and frozen nuclei preparations, attesting to the quality of FFPE nuclei (Supplementary Fig. 2a ). Furthermore, confocal imaging of FFPE and frozen nuclei revealed largely intact, DAPI-stained nuclei (Supplementary Fig. 1e ). Single FFPE and frozen nuclei from each peak were sorted into 96-well plates for WGA.
We next sought to define the effect of the DNA repair step on DNA extracted from FFPE nuclei. We compared repaired DNA from FFPE nuclei to a 'gold standard' (DNA from frozen nuclei) and tested whether the repair step would introduce artifacts (by comparing repaired and unrepaired frozen nuclei). Repaired and unrepaired sets of FFPE and frozen nuclei (from the 2N and 3N distributions) were sequenced ( Supplementary Table 1 ). Amplified DNA from FFPE and frozen nuclei were processed for multiplex sequencing as previously described 15 . Threshold cycle (C t ) values of real-time WGA reactions were used to approximate the relative abundance of amplifiable DNA molecules in frozen and FFPE samples from the repair versus norepair conditions. This qualitative analysis revealed that the relative amount of DNA template available for WGA was enhanced significantly by single-nucleus DNA repair (P < 0.0001, Mann-Whitney U test; Supplementary Fig. 1g ).
Multidimensional scaling of all of the single nuclei sequenced revealed two clusters. One cluster contained 'flat' (i.e., devoid of gene CN alterations) profiles (all derived from the 2N peak, presumably representing intratumor stromal and inflammatory cells) from FFPE and frozen samples, whereas the other cluster contained profiles from fresh/frozen and FFPE single cells that displayed CN alterations (CNAs) (frozen and FFPE nuclei, all derived from the 3N peak; Fig. 2c ), which were indicative of the cells' neoplastic origin. Consistent with this, bulk sequencing of DNA extracted from a population of 100,000 nuclei from the 2N and 3N peaks yielded similar CN profiles ( Fig. 2d and Supplementary  Fig. 3a,b) . Unrepaired FFPE single nuclei showed substantial bin-to-bin variability in normalized read-count data and an overabundance of CN segments, which were likely to be artifacts ( Supplementary Fig. 3d,e ). These artifacts were not observed in the datasets from the matched frozen and repaired FFPE samples ( Fig. 2e) . A systematic comparison of bin-to-bin variability ( Fig. 2e and Supplementary Fig. 3e ) and the concordance between CNAs detected in profiles from the unrepaired FFPE, repaired FFPE or frozen single nuclei and profiles from the bulk tumor ( Fig. 2d and Supplementary Fig. 3b ) revealed that single-nucleus DNA repair rendered the profiles of FFPE single nuclei comparable to those obtained from frozen single nuclei and bulk tumor samples. The CNAs detected in FFPE-repaired and frozen nuclei revealed high, significant correlations with the corresponding profiles from the bulk tumor (Spearman's correlation r 2 = 0.9058983 for FFPE-repaired nuclei and r 2 = 0.9116344 for frozen unrepaired nuclei; P < 2.2 × 10 −16 ). These analyses corroborated the idea that FFPE single-nucleus repair significantly improves the quality of the data. Notably, no significant differences between unrepaired and repaired frozen nuclei were observed ( Fig. 2e ), suggesting that CN artifacts potentially introduced by the single-nucleus DNA repair step are negligible.
Hierarchical clustering of CN profiles from FFPE (repaired) and frozen (unrepaired) 3N nuclei revealed that all nuclei harbored a highly rearranged genome and that FFPE and frozen single nuclei had concordant profiles ( Fig. 2f) . Clonal alterations identified through tumor bulk profiling were consistently present in the sequences of both FFPE and frozen nuclei ( Fig. 2g) . Two clonally related subpopulations that differed by a CN gain on chromosome 8 (8q21.3-q23.1) were detected in both repaired FFPE nuclei and frozen nuclei ( Fig. 2f ) and were evident in the CN profiles from the tumor bulk in the form of a non-integer subclonal CNAs (Supplementary Fig. 3c ).
Finally, an analysis of data for 2N single normal nuclei (i.e., presumably of stromal or inflammatory cell origin) from FFPE (repaired) and frozen (unrepaired) tissue showed that the percentage of the genome that deviates from CN = 2 (i.e., hypothetical ground truth) was negligible and not statistically different (average 0.63% and 0.38% for FFPE and frozen samples, respectively). Taken together, these results support the robustness and accuracy of the approach in retrieving genome-wide CN profiles from single FFPE nuclei.
Validation using breast cancer cell lines
Despite the high concordance between the CN profiles of FFPE and frozen nuclei from case 1 and their concordance with profiles of tumor bulks, one could argue that the genetic variation observed between individual nuclei may represent artifacts. Therefore, to investigate singlecell CN variation in a controlled setting, FFPE and frozen blocks of two commonly studied triploid breast cancer cell lines, MCF-7 and CAMA-1, were prepared. Flow cytometric analysis based on DAPI staining, forward scatter and side scatter ( Supplementary Figs. 2b and 4a ) was used to determine single-nucleus event rates in each preparation and were subsequently used to prepare 1:1 and 4:1 mixes (MCF-7:CAMA-1). The mixes were then used to make FFPE and frozen blocks. Blocks were processed as described for case 1, and for both conditions 96 cells per mix were sorted (cytometric parameters from both conditions t e c h n i c a l r e p o r t s were qualitatively similar; Supplementary Fig. 2) , amplified (only FFPE nuclei were repaired; Supplementary Fig. 1d ) and sequenced. In addition, bulk DNA from each cell line was sequenced.
Hierarchical clustering revealed that nuclei from MCF-7 and CAMA-1 clustered according to their specific CN profiles, irrespective of the procedure (FFPE and frozen) used to prepare the cells ( Supplementary Fig. 4b ). In addition, no differences between repaired FFPE, frozen nuclei and bulk data of each cell line in terms of binto-bin variance and CN concordance were observed ( Supplementary  Fig. 4b-d and Supplementary Table 1 ), attesting to the equivalence of sequencing methods used for FFPE and frozen single nuclei. The numerically lower concordances between the MCF-7 profiles (FFPE and frozen single nuclei) as compared to those for the CAMA-1 profiles stem from the higher genetic heterogeneity observed in this cell line, an observation supported by comparing single-cell to bulk data ( Supplementary Fig. 4b,e ).
The observed MCF-7:CAMA-1 ratios (i.e., with 50% and 20% CAMA-1 cells in repaired FFPE samples, and with 46% and 14% CAMA-1 cells in frozen samples), as defined by the CN profiles, were consistent with the theoretical mixing ratios (i.e., 50% and 20% CAMA-1 cells, respectively), providing evidence that with 96 cells sequenced, one can confidently detect a subclone comprising 20% of the tumor bulk ( Supplementary Fig. 4f ). Furthermore, downsampling analysis of the single nuclei from 96 to 48 (in both 4:1 mixes) revealed that the clone comprising 20% of the mix could be detected accurately using 48 single nuclei (Supplementary Table 1 ).
Analysis of synchronous ductal carcinoma in situ and invasive disease
To illustrate the potential of this single-cell CN analysis method to address biologically relevant questions, we used it to study breast cancer progression and selected for analysis two cases of synchronously diagnosed DCIS and invasive breast cancer ( Figs. 3 and 4) . Areas of DCIS and invasive cancer ( Figs. 3a and 4a ) from FFPE and frozen blocks were separately microdissected 5 , and nuclei were prepared as described above. A fraction of the nuclei was used for bulk tumor sequencing.
Polyploid case 2
Flow cytometry data of both components from FFPE and frozen tissues were of similar quality (Supplementary Fig. 2c ). Both DCIS and invasive samples showed two DNA content distributions at 2N (diploid) and ~4N (near-tetraploid) ( Fig. 3b and Supplementary Fig. 5a ). Sequencing of the frozen 2N nuclei from the DCIS sample revealed all to be genomically normal ( Supplementary Fig. 5b ), whereas the ~4N nuclei had rearranged genomes ( Fig. 3c) . We thus focused on the ~4N nuclei from the cancer sample.
Similar to what was performed for case 1, single nuclei from the ~4N distribution were analyzed under three conditions: (i) FFPE-repaired, (ii) FFPE-unrepaired and (iii) frozen-unrepaired. Consistent with the results of case 1, unrepaired FFPE nuclei yielded artifactual results (i.e., non-integer CN states; Supplementary Fig. 6a,b) , whereas the introduction of the single-nucleus DNA repair step resulted in the detection of CNAs that were mostly concordant with those detected in frozen nuclei and the matching profiles from the tumor bulk ( Fig. 3c,d and Supplementary Fig. 6c ). Spearman's correlations between CNAs detected in the FFPE and frozen nuclei and the matching tumor bulks were significant (P < 2.2 × 10 −16 ) and similar to one another (r 2 = 0.7627261 for FFPE; r 2 = 0.7802684 for frozen). Correlations were numerically but not statistically significantly lower than those of case 1, probably owing to the profound ITGH in case 2 (Fig. 3e) .
Hierarchical clustering of all nuclei sequenced (60 DCIS FFPE, 60 invasive FFPE, 60 DCIS frozen and 60 invasive frozen; Supplementary Table 1 ) illustrated the robustness and accuracy of the data with all single nuclei showing, among other clonal events, a gain of chromosome 1q and losses of chromosomes 11q and 22 ( Fig. 3c,e,f) . Focal amplifications on chromosome 17q encompassing the receptor-tyrosine-kinase-encoding ERBB2 gene (also known as HER2; 17q12-q21.2), the phosphatase-encoding PPM1D gene and the microtubule-associated cell migration factor-encoding BCAS3 gene (17q22-q23.2) were also observed in all of the nuclei sequenced ( Fig. 3c,e ). Subclonal events, such as losses of chromosomes 1p and 8p and alterations on chromosomes 5 and 8, were found in the profiles from the DCIS and invasive tumor samples from both FFPE and frozen tissue ( Fig. 3e,g) . Taken together, the presented data, along with the fact that FFPE and frozen single cells clustered together observed in the heat map ( Fig. 3e) , further support the robustness of CN profiling of nuclei retrieved from FFPE samples.
We next defined subpopulations (i.e., clades) on the basis of the conservatively estimated cut-points of the dendrogram (Fig. 3e , dashed line). Six distinct but highly related subpopulations were identified ( Fig. 3e) . For all six clades, the constituting nuclei were derived from both the in situ and invasive components. This implies that either invasion was unrelated to the CNAs or the ability to invade was acquired early in disease development (i.e., in situ disease) followed by genome instability and the development of multiple genetically heterogeneous DCIS subclones that in parallel progressed to invasive disease ( Supplementary Fig. 7a ).
Diploid case 3
Flow cytometry analysis of the DCIS and invasive components showed diploid (2N) profiles (Fig. 4b) . Forty-eight FFPE-repaired and frozen diploid nuclei from both DCIS and invasive disease were Table 1 ). FFPE-repaired single nuclei gave qualitatively similar CN profiles to those of frozen nuclei and were concordant with the CN profiles derived from tumor bulk wholeexome sequencing (WES) (Supplementary Fig. 8a-c) . Hierarchical clustering of all nuclei revealed the presence of two major groups, one with genomically normal cells and another with rearranged, clonally related cancer cells from the DCIS and invasive components (Fig. 4c) . Clonal alterations identified in the analysis of the matched frozen bulk tumor tissue, such as loss of chromosomes 13q (containing the RB transcriptional co-repressor 1 (RB1) gene locus) and 17p (containing t e c h n i c a l r e p o r t s p53-encoding TP53 gene locus), as well as focal amplifications on chromosomes 8p11.2-p12 (containing fibroblast growth factor receptor 1 (FGFR1) gene locus) and 11q13.3-q13.4 (containing cyclin D1 (CCND1) gene locus), were detected in all single FFPE and frozen nuclei (Fig. 4c, orange arrows, and Supplementary Fig. 8c) . Subclonal events included a gain in chromosome 20p-20q (20p11.21-q13.33), a loss of chromosome 9 and segmental losses at chromosomes 3p21.31-p12.3 and 3q21.2-q24 ( Fig. 4c, black arrows) . These and other subclonal alterations defined several distinct clusters, which were restricted to either the DCIS (DC-1, DC-2, DC-3 and DC-4) or the invasive (IC-1 and IC-2) component ( Fig. 4c and Supplementary  Fig. 8d) . These clusters were found to be robust, given the low (<10 −15 ) probability of each subcluster of cells within a cluster sharing a set of break points by chance (Online Methods). On the basis of the identified subclones, some of which were validated at similar clonal frequencies by fluorescence in situ hybridization (FISH) ( Fig. 4d,  Supplementary Table 2 and Supplementary Fig. 9 ), we sought to define the likely evolutionary process that occurred during disease progression (Fig. 4e) . The reconstructed phylogeny of case 3 suggests a scenario in which ITGH occurred early in disease development and progression from DCIS to invasive carcinoma might have occurred via clonal selection ( Fig. 4e and Supplementary Fig. 7b) . Notably, this putative evolutionary bottleneck was associated with a homozygous deletion at the phosphatase and tensin homolog (PTEN) locus ( Fig. 4d and Supplementary Fig. 8b,d) , an observation validated by FISH with PTEN-specific probes ( Fig. 4d and Supplementary Fig. 9 ).
We next asked whether the clonal selection process deduced from the single-cell-reconstructed phylogeny of case 3 could also be evidenced in the mutational space extracted from WES of the tumor bulk. Indeed, WES data analysis from microdissected DCIS and invasive components also indicated progression from in situ to invasive disease, resulting in clonal shifts with a reduction in clonal diversity in the latter (Supplementary Fig. 10) .
Single-cell CN information from suboptimal FFPE samples
Although we focused our analysis on FFPE samples yielding ≥300 bp fragments in the multiplex-PCR assay, we asked whether it was also possible to retrieve accurate CN information from suboptimal (i.e., overly damaged) FFPE samples. Thus, we analyzed an additional case (case 4; Fig. 5a ), which yielded 200-bp fragments in the multiplex-PCR assay, even after single-nucleus DNA repair ( Supplementary  Fig. 1a ). This analysis revealed that clonal alterations, identified in WES of the tumor bulk and matched data from frozen single nuclei, were found in all FFPE-repaired single nuclei sequenced (Fig. 5b,c) , and in the case of the clonal ERBB2 (HER2) amplification, which was confirmed by FISH analysis (Fig. 5d) . The overall pattern of CNAs of FFPE-repaired and frozen single nuclei was similar; however, frozen nuclei preferentially clustered together (Fig. 5e ). Whether this was due to geographic heterogeneity or the overly damaged nature of the sample is unclear and requires analysis of additional overly damaged FFPE samples. Nonetheless, our findings suggest that even in relatively degraded samples, our method is capable of capturing clonal alterations at the single-nucleus resolution.
DISCUSSION
Here we describe the first method for the genome-wide CN profiling of single nuclei using routinely processed FFPE clinical samples. Aspects germane to the success of this methodology were: (i) selection of FFPE samples based on objective assessment of DNA quality or size, (ii) the implementation of a variety of treatments to retrieve intact nuclei, and (iii) the introduction of a single-nucleus DNA repair step. Using this approach, the single-cell CN information obtained from FFPE samples was highly concordant with that obtained from matched frozen samples and the corresponding CN profiles of the bulk tumor tissue. The consistent detection of clonal and subclonal CN events in FFPE and matched frozen cells highly supports the sensitivity and reproducibility of the method.
Although our methodology allows CN assessment of FFPE singlecell genomes, the WGA strategy we used carries an intrinsic limitation. The poor breadth of coverage associated with DOP-PCR renders our approach unsuitable for applications such as single-cell WES. WGA methods that allow for high coverage of single-cell genomes, however, are currently not compatible with amplifying DNA from FFPE samples 17 . Hence, the detection of nucleotide substitutions, small insertions and deletions, or rearrangements in FFPE single cells, either alone or in combination with CN profiling, will require further development. Another limitation of the method described here is that it performs optimally in FFPE samples with good-quality DNA, which may account for approximately 50% of the samples depending on the fixation protocols used. The multiplex-PCR method described as part of the sample work-up, however, provides an upfront assessment of the samples that are likely to yield optimal results. The technical failure rate in samples with PCR fragments >300 bp is likely to be minimal, given that all samples analyzed in this study that passed the quality-control PCR yielded high-quality single-cell CN data and that FFPE breast cancer tumor bulk samples with even lower fragment sizes have been successfully used for the analysis of CNAs 23 .
Nonetheless, the methodology developed here can potentially unlock pathology archives by providing access to a large repository of material for single-cell genomics, which could be used for detailed studies of cancer evolution and the chronology of somatic genetic events in cancer development and progression, in particular in the progression from pre-invasive lesions (for example, DCIS or lobular carcinoma in situ) to invasive breast cancer and from primary breast cancers to metastatic lesions for which only limited, and FFPE, tumor material is available. This could facilitate biomarker discovery in the form of indices of ITGH for prognostication and prediction, identification of clonal versus subclonal genetic alterations, and co-occurrence or mutual exclusivity of specific somatic subclonal genetic alterations within the cancer cell populations of a tumor through retrospective analysis of archived, clinically annotated FFPE samples obtained from clinical trials or available in pathology departments. The method also has the potential to inform the underlying genetics and biology of cancer, as illustrated by the results from matched DCIS and invasive samples. Our study provides evidence at single-cell resolution to support different mechanisms for the progression from DCIS to invasive breast cancer (Supplementary Fig. 7) , suggesting that progression from in situ to invasive disease is complex and may vary from patient to patient. In some cases the ability to invade may be an intrinsic characteristic acquired early in the development of the DCIS, whereas in others it may be the result of selection of an invasive clone. It should be noted, however, that synchronous DCIS and invasive breast cancer samples were analyzed here; further studies to define the progression of pure DCIS (i.e., diagnosed in the absence of invasive disease and treated surgically with or without radiation therapy) to invasive breast cancer are warranted. Given that in FFPE samples, histologic features can be optimally obtained, this method will allow for detailed genotypic-phenotypic analyses through the observation and dissection of phenotypically distinct components within FFPE tumor tissues followed by single-cell genomic analyses, as illustrated by the DCIS and invasive breast cancers described in this study.
Taken together, our results demonstrate the reproducibility and accuracy of the single-cell FFPE CN profiling method described here and illustrate its potential to unravel ITGH in cancers, dissect the genetics of histologically or phenotypically distinct cancer components, and trace their evolutionary history.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
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ONLINE METHODS
Case selection and sample labeling. FFPE and frozen blocks from case 1 (2008) were purchased from the UMass Cancer Center Tissue and Tumor Bank, University of Massachusetts. FFPE and frozen blocks from the remaining samples analyzed-including those from cases 2-4, which comprise synchronous DCIS and invasive breast cancer-were retrieved from the Memorial Sloan Kettering Cancer Center (MSKCC) pathology archives ( Table 1) . All cases were reviewed by J.S.R.-F. and F.C.G., who classified the tumors following the World Health Organization (WHO) criteria 31 and identified DCIS and invasive components for subsequent microdissection. Estrogen receptor (ER), progesterone receptor (PR) and ERBB2 (HER2) status was assessed as previously described 32 , following the American Society of Clinical Oncology (ASCO)-College of American Pathologists (CAP) guidelines 33, 34 . This study was approved by the MSKCC institutional review board (IRB number: WA0174-13), and informed consent was obtained where appropriate according to the protocol approved.
Sample preparation, microdissection and single-nucleus preparation.
Up to three 100-µm-thick sections were cut onto positively charged microscope slides. Sections were washed three times with 1 ml xylene for 5 min to remove the paraffin, rehydrated in sequential 5-min-long ethanol immersions (2 × 100% ethanol, followed by 1 wash each with 95%, 70%, 50% and 30% ethanol), stained with nuclear fast red (NFR, Sigma-Aldrich) and dehydrated by reverse sequential (30%, 50%, 70%, 95% and 100%) ethanol washes. The areas of interest were microdissected as previously described 5 , washed three times at 90 °C for 60 min with 1 ml of Tris-EDTA pH 9.0 (IHC antigen retrieval reagent, Enzo) or 5 mM EDTA buffer pH 8 (Sigma-Aldrich) to facilitate the removal of the cross-links (i.e. reverse cross-linking) present in the FFPE tissues. Samples were cooled at room temperature (RT) and washed four times (3 × 1.2-ml wash and 1 × 800-µl final wash) with phosphate-buffered saline (PBS) supplemented with 0.5 mM CaCl 2 to remove EDTA. The tissues were digested for 16 h at 37 °C in 1 ml of an enzymatic cocktail containing 1 mg/ml of Collagenase or Dispase (Roche) and 100 units/ml of Hyaluronidase (Calbiochem) in PBS with 0.5 mM CaCl 2 . Next, 400 µl NST buffer (146 mM NaCl, 10 mM Tris base at pH 7.8, 1 mM CaCl 2 , 21 mM MgCl 2 , 0.05% BSA, 0.2% Nonidet P-40) was added to the samples, and the sample was centrifuged for 7 min at 5,000 r.p.m. The pellets were resuspended in 800 µl of NST-DAPI (DAPI; 10 µg/ml), 0.1% DNase-free RNase A and 10% fetal bovine serum (Life Technologies), partially disaggregated by pipetting and passed through a 25-G needle at least 30 times. Nuclear suspensions were washed an additional three times with 800 µl of NST-DAPI, then filtered twice through a 35-µm strainer mesh and collected into a polystyrene round-bottom FACS tube. Samples were rested on wet ice for immediate sorting or supplemented with 10% DMSO for cryopreservation at −80 °C. Frozen samples were processed in a similar manner but with modifications due to the fragile nature of fresh/frozen nuclei. The 100-µm-thick sections were maintained on ice whenever possible; all washes (including with the NFR solution and washes during staining) were done using 0.5 mM CaCl 2 /PBS, and hydration-dehydration immersions were carried out using ethanol dilutions with 0.5 mM CaCl 2 /PBS.
Nuclear DNA extraction and multiplex-PCR assay. DNA from nuclear preparations was isolated using the PureLink DNA Mini Kit (Life Technologies). Fifty nanograms of DNA was subjected to template restoration using PreCR Repair Mix (New England BioLabs) in a reaction containing 1× ThermoPol buffer, 100 µM dNTPs, 1× NAD + , 1 µl of PreCR mix and water to 50 µl, incubated 20 min at 37 °C. The restored DNA was concentrated using the DNA Clean and Concentrator (Zymo Research), and identical amounts of repaired and unrepaired bulk DNA were subjected to multiplex PCR as previously described 23 but with minor modifications. The PCR reaction was performed with four primer sets that produce 100-bp, 200-bp, 300-bp and 400-bp fragments from non-overlapping target sites in the glyceraldehyde-3-phosphate dehydrogenase gene (GAPDH; on chromosome 12) in 25 µl, with final concentrations of 0.133 µM of each of the eight primers ( Supplementary Table 3 ) and 1× AmpliTaq Gold 360 DNA Master Mix. Multiplex PCR was conducted as follows: 5 min at 95 °C, 37 cycles each of 15 s at 95 °C, 15 s at 55 °C and 30 s at 72 °C, followed by 5 min at 72 °C. Fifteen microliters of PCR product was loaded on a 2% TAE agarose gel and electrophoresed. Samples (unrepaired) were classified based on the largest of four possible PCR products detected. Unrepaired and repaired DNA samples were run side by side for comparison purposes (Supplementary Fig. 1 ).
DNA fluorescence in situ hybridization (FISH) analysis. FISH analysis for case 3 was performed using four three-color probe panels on sequential sections of two frozen tissue blocks. Probe panel 1 consisted of bacterial artificial chromosome (BAC) clones spanning CCND1 (11q13) (RP11-300I6, RP11-804L21; labeled with green dUTP), SRC (20q11) (RP11-151C5, RP11-451G10; labeled with red dUTP) and GNAQ (9q21) (RP11-747P3, RP11-574G7; labeled with orange dUTP). Probe panel 2 consisted of BAC clones spanning CCND1 (11q13) (RP11-300I6, RP11-804L21; labeled with green dUTP), PTEN (10q23) (RP11-165M8, RP11-765C10; labeled with red dUTP) and OCIAD1 (4p14) (RP11-36B15; labeled with orange dUTP). Probe panel 3 consisted of BAC clones spanning CCND1 (11q13) (RP11-300I6, RP11-804L21; labeled with green dUTP), PTEN (10q23) (RP11-165M8, RP11-765C10; labeled with red dUTP) and the chromosome 10 centromeric region (CEN) (p10RP8; labeled with orange dUTP). Probe panel 4 consisted of BAC clones spanning CCND1 (11q13) (RP11-300I6, RP11-804L21; labeled with green dUTP), OCIAD1 (4p14) (RP11-36B15; labeled with orange dUTP) and chromosome 4 CEN (RP11-365H22, RP11-779E21; labeled with red dUTP). FISH analysis for case 4 was performed using a two-color ERBB2-centromeric chromosome 17 (CEP17) probe. The probe mix consisted of BAC clones containing the ERBB2 gene (RP11-94L15, RP11-62N23 and CTD-3211L18; labeled with red dUTP) and a centromeric repeat plasmid for chromosome 17 (clone p17H8p; labeled with green dUTP). Probe labeling, tissue processing, hybridization, post-hybridization washing and fluorescence detection were performed according to standard lab procedures 35 . Slides were scanned using a Zeiss Axioplan 2i epifluorescence microscope equipped with a CCD camera (CV-M4+CL, JAI) controlled by Isis 5.5.9 (MetaSystems Group Inc.). Each probe panel was hybridized on a separate unstained slide and the corresponding H&E slide or image was used to identify regions of DCIS or invasive ductal carcinoma (IDC). The entire section was first scanned under a 63× objective to assess signal pattern. Normal breast epithelium and stromal elements served as the controls (internal controls: normal tissues adjacent to the lesions; external controls: three distinct normal breast tissue samples) to assess quality of hybridization and nuclear truncation (i.e., nuclei present only in part in the histologic section). At least five images per representative region were captured, and a minimum of 50 discrete nuclei were scored per region (each image was a compressed stack of 12 z-section images taken at 0.5-µm intervals). For case 3, the distinct probe panels were used to validate and map the location of the distinct DCIS and IDC subclones that were previously identified by singlecell sequencing. For assessment of ITGH in case 3 and ERBB2 amplification in case 4, we followed the ASCO-CAP guidelines 33 .
Cell line culture conditions. MCF-7 and CAMA-1 cells were purchased from the American Type Culture Collection (ATCC), authenticated and tested for mycoplasma contamination as previously described 36, 37 , and maintained in 5% CO 2 -humidified atmosphere at 37 °C in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FBS, 2 mM l-glutamine and 1% penicillin-streptomycin (Life Technologies).
Confocal imaging of FFPE and frozen nuclei.
Nuclei derived from FFPE and frozen tissues from cases 1 (tumor) and 2 (tumor and normal) were mounted with ProLong Gold Antifade Reagent with DAPI (Life Technologies). Stacked fluorescence images (40-70 stacks/image) were acquired using a Leica TCS SP5-II Upright microscope (Leica Microsystems). Maximum-intensity projection images from Supplementary Figure 1e were generated using Fiji (ImageJ 2.0.0-rc-43-1.50e).
Formalin-fixed paraffin-embedded (FFPE) and frozen cell line pellet block preparation.
The content of one confluent T-75 flask for each cell line (MCF-7 and CAMA-1) was split into two identical aliquots and pelleted by centrifugation at 800 r.p.m. for 5 min. For FFPE blocks, the pellet was incubated for 1 h in 10% neutral-buffered formalin at RT, then resuspended in 100 µl warm HistoGel (Thermo Scientific) and placed on ice for solidification. Solidified HistoGel pellets were then processed following the same routine protocol used for diagnostic pathology specimens at MSKCC. For frozen blocks, the pellet was resuspended in O.C.T (Tissue-Tek) and placed on dry ice for solidification. Suspensions of nuclei were prepared exactly as described above for tumor-derived tissue samples. To prepare accurate mixes (1:1 and 4:1, MCF-7: CAMA-1), cytometric analyses were performed for both FFPE and frozen nuclei preparations of each cell line. The number of total events/s and the percentage of single-cell events for FFPE MCF-7, FFPE CAMA-1, frozen MCF-7 and frozen CAMA-1 were determined and used to compute the fraction of single-cell events per nuclear preparation, which were used to prepare the mixes for sorting.
Flow cytometry analysis and sorting of single nuclei. Sorting of single nuclei was performed using a FACSAria II SORP (BD Biosciences). The DAPI signal was detected by a 355-nm ultraviolet (UV) laser (450/50 bandpass filter). Gains were set for the UV photomultiplier based on the DNA content equivalent to human diploid lymphoblast cells. Prior to FACS, a cytometric analysis of ploidy (i.e., DNA content) distributions within each tumor sample was performed and compared to that of a diploid control sample (derived from a lymphoblastoid cell line from a healthy individual) to determine accurately the diploid peak position within the tumor and establish FACS collection gates. Single nuclei were determined by doublet discrimination as described by Wersto et al. 38 . Single cells were deposited into individual wells of a 96-well plate containing 10 µl of 1× Single Cell Lysis and Fragmentation Buffer and proteinase K (Sigma-Aldrich).
Single-nucleus DNA repair and whole-genome amplification. Immediately after sorting, single nuclei retrieved from microdissected FFPE samples were incubated at 50 °C for 2 h and stored at −80 °C until further use. Given that the nuclear DNA of cases 3 and 4 was found to be fragmented (multiplex-PCR assay, Supplementary Fig. 1) , the non-enzymatic random fragmentation prior to OmniPlex library generation was omitted . For cases 1 and 2, and the cancer cell lines, whose DNA was found to be of high quality (multiplex-PCR assay; Supplementary Fig. 1) , a 2-min heating period at 99 °C (i.e., fragmentation to ~400 bp) was included. Single-nucleus DNA repair was performed before WGA by adding 1.3 µl of 10× ThermoPol Reaction Buffer, 0.26 µl of 50× dNTPs/NAD + mix (5 mM/25 mM), 1.18 µl of water and 0.26 µl of PreCR mix (NEB) to the 10-µl nuclear lysis reaction and incubating the reaction for 30 min at 37 °C. Repaired DNA was then directly combined with 2.6 µl 1× Single-Cell Library Preparation Buffer and 1.3 µl Library Stabilization Solution, mixed thoroughly and placed in a thermocycler at 95 °C for 2 min. The sample was then cooled to 4 °C, briefly spun down and supplemented with 1.3 µl of Library Preparation Enzyme, mixed thoroughly, placed in a thermocycler and incubated as follows: 16 °C for 20 min, 24 °C for 20 min, 37 °C for 20 min, 75 °C for 5 min and cooling to 4 °C. These OmniPlex libraries were then combined with 44.3 µl of water and 7.5 µl of 10× Amplification Master Mix, mixed thoroughly and placed in a thermocycler, which was heated at 94 °C for 3 min followed by 28 (cases 1 and 2) or 30 (cases 3 and 4) cycles of 94 °C for 30 s and 65 °C for 5 min. Alternatively, repaired DNA was bead-purified with ~1.8-2:1 AMPure beads:DNA ratio for 20 min, washed three times with 80% ethanol, eluted in 10 µl of 1× Single Cell Lysis and Fragmentation Buffer (or TE pH 8) and subjected to standard WGA4 protocol for 28-30 cycles of amplification. Unrepaired DNA samples extracted from FFPE nuclei were subjected to identical cycling conditions. WGAs were assessed on a 1.5% agarose gel to confirm amplification, and positive samples were processed further. Successful WGA reactions yielded ~50 µl of material at >100 ng/µl and had a WGA product spread between 100 bp and 800 bp. Frozen nuclei WGAs were performed following the standard protocol 15 .
For real-time WGA, the amplification reactions were supplemented with 0.1× SYBR Green (Sigma-Aldrich) and 1 µl of ROX reference dye (Life Technologies) and were run in a StepOne Plus Real-Time PCR System (Applied Biosystems). Comparisons were performed using the Mann-Whitney U test (GraphPad Prism 6).
Illumina library preparation, library pooling and multiplex sequencing.
Five hundred nanograms of WGA products were acoustically sonicated using the Covaris E210focus acoustics system (Covaris)-duty cycle: 10%, intensity: 4, cycle/bust: 200, and time: 80 s. The sonicated WGA was endrepaired, deoxy-AMP, deoxyadenosine monophosphate (dA)-tailed and barcoded (indices listed in Supplementary Table 3 ) following standard Illumina protocols. The FFPE and frozen indexed or barcoded libraries were pooled, PCR-enriched (primers listed in Supplementary Table 3 ) and assessed for quality before sequencing on a HiSeq instrument (paired-end 76, 101 or single-read 76 Illumina sequencing runs).
Bioinformatics analysis of single-cell sequencing data. Single-cell sequencing data were processed and analyzed as previously described 2, 14, 15 . In brief, sequence reads were mapped using Bowtie 39 , PCR duplicates were removed, and sequencing reads were indexed using SAMtools 40 . Uniquely mapping reads were counted for each bin and normalized for GC bias using lowess smoothing. Normalized read-count data were then segmented using circular binary segmentation (CBS) 41 . For CN determination, we used our previously published approach based on least-squares fitting 14 . Briefly, for single-cell data the CN at any position (bin) along the genome must be an integer value. In the case of a normal female diploid genome, the value of the CN in the majority of bins is expected to be 2, thus, the best-fit multiplier is 2. For rearranged cancer cells (i.e., cancer cells with CNAs), for which the CN of genome segments is unknown, the normalized bin count data is iteratively multiplied by 81 values ranging from 1.5 to 5.5 (in 0.05 increments). Next, a 'quantal error' is computed for each multiplier, which is the sum of the squared difference between the multiplied segmented profile values and their nearest-integer-rounded counterparts. The multiplier that minimizes the quantal error is deemed as the best fit and used to estimate CN. Given that the ploidy of the tumor cells for each case was pre-estimated based on flow cytometry data, the thresholds of the multiplier were further constrained within the range determined by flow cytometry. All genome-wide CN profiles illustrated in the figures were constructed using 20k bin data resolution 14 . Given the coverage the samples were sequenced at, the analysis allowed for accurate determination of CN states between 0 and 7 at a resolution of roughly 700 kb. It also allows the capture of higher CN states in the form of amplifications. It should be noted, however, that for amplifications, the CN at a particular state in a collection of single cells was observed as a tight distribution of CN values.
Code availability. The code used for the single-cell sequencing data analysis is available in Baslan et al. 15 .
Bin-to-bin variance calculation. Noise in the read-count data (bin-to-bin variance) was calculated by taking the summation of the square of the differences between the values of the normalized read count and the segmented data for all 5k bins 14 . The data were plotted in box-plot format for each experimental group to illustrate subgroup variance.
Percent-genome-match analysis between single cells and corresponding bulk samples.
Concordance of the CN at a particular bin between the singlecell and the corresponding bulk data was taken as a relative measure of accurate CN calling. For this, the percentage of matching bins, across all 5k bins, was calculated for each single cell and plotted in the form of box plot for each experimental condition. This was calculated for datasets that were rounded to the nearest integer following the least-square-fitting algorithm CN estimation for the single-cell and bulk data. This represents a lower bound for the accuracy measure, as regions that display subclonality in the bulk, and hence are not at integer CN states, are rounded to the nearest integer and, therefore, are expected to be discordant with the values of a subset of the single-cell data.
Calculation of the number of single cells to sequence.
To estimate a suitable number of single cells for sequencing, binomial statistics was used to calculate the power to observe a particular genetic alteration in single-cell data in 10%, 15% and 20% of the single cells. With the requirement of a particular alteration being found in a minimum of three single cells, it was determined that sequencing 48 single cells gives sufficient power to observe subclonal alterations at the aforementioned percentages.
False-positive estimates. False-positive estimation was calculated using nonrearranged (i.e., flat) single-cell data. Estimation was performed by assuming that for these cells any deviation from CN = 2 in the autosomal bins represents a false positive. The percentage of bins that show this deviation was calculated for all cells, and the average was computed. These calculations represent an upper bound of the false-positive estimates, as CNAs detected in single cells may actually represent somatic CNAs.
Coverage uniformity and GC-content bias. We used Ginkgo 29 (http:// qb.cshl.edu/ginkgo) to compute and plot the coverage uniformity (Lorenz curve_ENREF_47; ref. 28 ) and the GC bias of repaired and unrepaired single nuclei.
Hierarchical clustering and multidimensional scaling. Hierarchical clustering heat maps were constructed using CN profiles of individual cells at 5K resolution 20 using Manhattan distance function and Ward's clustering method. For multidimensional scaling (MDS), classical MDS was implemented using Euclidean distances, with k = 2 dimensions.
Statistical analysis of clustering. To estimate the probability of observing a cluster of cells that shared a group of break points, we estimated the falsepositive breakpoint rate, p, from the normal-like diploid FFPE cell population, assuming as an upper bound that all events in this population were falsepositive calls. To estimate the probability of observing Nc or more cells out of N cells sharing B break points, we computed Σ (i = Nc − 1) N (N¦i) p Bi (1 − p B ) (N − i) . For the statistical analysis comparing FFPE and frozen normal cells, we used the Mann-Whitney U test.
Low-pass whole-genome sequencing and analysis. Libraries were prepared and analyzed as described in Baslan et al. 14 
.
Whole-exome sequencing of case 3 and bioinformatics analysis. Case 3 WES was performed in two sets of samples (plus matching normal) for each component, namely DCIS-1/IDC-1 and DCIS-2/IDC-2. The whole-exome capture for DCIS-1 and IDC-1 was performed using the NimbleGen SeqCap EZ Human Exome Library v2.0 (Roche), following the manufacturer's protocol. The whole-exome enrichment for DCIS-2 and IDC-2 was performed with SureSelect Human All Exon v4 (Agilent Technologies), following the manufacturer's protocol. The exon-enriched libraries were subjected to 2× 76-bp paired-end sequencing on an Illumina HiSeq2000 instrument. The median depths of coverage were 138× (range 125-150×, DCIS-1/IDC-1) and 203× (range 93-217×, DCIS-2/IDC-2) ( Supplementary Table 4 ). Bioinformatics analysis was conducted exactly as previously described 4 . CN alterations were inferred from MPS data using FACETS 42 and genes with altered CN were determined adopting the methods described in Curtis et al. 43 . Gene amplification, homozygous deletion and loss of heterozygosity events were visually reviewed using plots of raw log 2 and allele ratios.
The cancer cell fraction (CCF) of each mutation was inferred using the number of reads supporting the reference and the alternate alleles and the segmented log 2 ratio from WES as input for ABSOLUTE (v1.0.6) 11 . Solutions from ABSOLUTE were manually reviewed as described 11, 44 . A mutation was classified as clonal if its probability of being clonal was >50% or if the lower bound of the 95% confidence interval of its CCF was >90%, as previously described 45 .
Phylogeny reconstruction. CN and mutation based phylogenetic trees were made using the R package Phangorn 46 , with the maximum parsimony optimality criterion, as previously described 45 . The levels for the mutational tree were binary, based on the presence or absence of the mutations within each sample.
For the CN data the levels of alteration were categorized as homozygous deletion, loss, unchanged, gain and amplification. The Bioconductor package CGHregions 47 was used for dimension reduction of the CN alteration matrix, to minimize the weight of large alterations, and the resulting matrix was used as input for Phangorn.
Representation of the evolutionary path based on single-cell data from case 3 was constructed manually using the subclonal information inferred from the breakpoint probability analysis, identified clonal alterations, and the calculated relative abundance of each identified subclone, essentially as previously described 48 .
Statistical analysis. Comparisons of C t values to define the template DNA available in WGA nuclei using real-time SYBR Green reactions were performed using the Mann-Whitney U test (GraphPad Prism 6). Spearman's correlations were employed to define the correlations between single-cell and bulk CN profiles.
Data availability statement. Single-cell, low-pass whole-genome and wholeexome sequencing data have been deposited in the Sequence Read Archive (SRA) under accession SRP008292.
